167 related articles for article (PubMed ID: 24378597)
1. T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease.
Arias-Guillén M; Riestra S; de Francisco R; Palacios JJ; Belda J; Escalante P; Pérez-Martínez I; Molinos LM; Garcia-Clemente M; Pando-Sandoval A; Rodrigo L; Prieto A; Martínez-Camblor P; Losada A; Casan P
Inflamm Bowel Dis; 2014 Feb; 20(2):329-38. PubMed ID: 24378597
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis.
Igari H; Ishikawa S; Nakazawa T; Oya Y; Futami H; Tsuyuzaki M; Suzuki K; Matsumura R
J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459
[TBL] [Abstract][Full Text] [Related]
4. Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Shahidi N; Fu YT; Qian H; Bressler B
Inflamm Bowel Dis; 2012 Nov; 18(11):2034-42. PubMed ID: 22294550
[TBL] [Abstract][Full Text] [Related]
5. Predictors of discordant latent tuberculosis infection test results amongst South African health care workers.
Adams S; Ehrlich R; Baatjies R; Dendukuri N; Wang Z; Dheda K
BMC Infect Dis; 2019 Feb; 19(1):131. PubMed ID: 30736743
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
7. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.
Vassilopoulos D; Tsikrika S; Hatzara C; Podia V; Kandili A; Stamoulis N; Hadziyannis E
Clin Vaccine Immunol; 2011 Dec; 18(12):2102-8. PubMed ID: 21994356
[TBL] [Abstract][Full Text] [Related]
9. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
[TBL] [Abstract][Full Text] [Related]
11. Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV).
Pettit AC; Stout JE; Belknap R; Benson CA; Séraphin MN; Lauzardo M; Horne DJ; Garfein RS; Maruri F; Ho CS;
Clin Infect Dis; 2021 Oct; 73(7):e2278-e2284. PubMed ID: 32761083
[TBL] [Abstract][Full Text] [Related]
12. The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy.
Mantzaris GJ; Tsironikos D; Tzanetakou X; Grispou E; Karatzas P; Kalogeropoulos I; Papamichael K
Scand J Gastroenterol; 2015; 50(12):1451-5. PubMed ID: 26139305
[TBL] [Abstract][Full Text] [Related]
13. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting Tuberculosis Disease.
Ayers T; Hill AN; Raykin J; Mohanty S; Belknap RW; Brostrom R; Khurana R; Lauzardo M; Miller TL; Narita M; Pettit AC; Pyan A; Salcedo KL; Polony A; Flood J;
JAMA Netw Open; 2024 Apr; 7(4):e244769. PubMed ID: 38568690
[TBL] [Abstract][Full Text] [Related]
15. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
[TBL] [Abstract][Full Text] [Related]
16. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.
Saracino A; Scotto G; Fornabaio C; Martinelli D; Faleo G; Cibelli D; Tartaglia A; Di Tullio R; Fazio V; Prato R; Monno L; Angarano G
New Microbiol; 2009 Oct; 32(4):369-76. PubMed ID: 20128443
[TBL] [Abstract][Full Text] [Related]
17. Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients.
Chung WK; Zheng ZL; Sung JY; Kim S; Lee HH; Choi SJ; Yang J
Clin Microbiol Infect; 2010 Jul; 16(7):960-5. PubMed ID: 19906274
[TBL] [Abstract][Full Text] [Related]
18. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children.
Lucas M; Nicol P; McKinnon E; Whidborne R; Lucas A; Thambiran A; Burgner D; Waring J; French M
Thorax; 2010 May; 65(5):442-8. PubMed ID: 20435869
[TBL] [Abstract][Full Text] [Related]
19. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.
Kim JS; Cho JH; Park GY; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transplant Proc; 2013 Oct; 45(8):2899-902. PubMed ID: 24157000
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
